Here, we investigated the role of CD300a in tumor development and demonstrate that CD300a inhibits TEV-mediated interferon-β (IFN-β) production by DCs and suppresses the activation of tumor-infiltrating Treg cells and tumor development. The gene discussed is IFNB1; the disease is neoplasm.